+
Site Tour

LAAO 2023: What's new – Leaks or DRT – which is the lesser of two evils?

Xavier Freixa presents a talk on leaks and device related thrombus, providing clinical data and information on predicting thrombus.

Watch on Demand videos on LAAO Summit 2023

Related Videos

LAAO Summit 2023: Neurology

LAAO Summit 2023: CT

LAAO Summit 2023: Minimal anti-thrombotic therapy

LAAO Summit 2023: Lag and leap

LAAO Summit 2023: Leaks

LAAO Summit 2023: LAAO device

ESOC 2023: LAAO case

LAAO Summit - Debate: Factor XI inhibitors

TAVI Summit - Cardiac imaging

LAAO Summit 2023: LAA anatomies

LAAO Summit - Mastering leaks

Trending Controversies | AV Valves

TRENDING TOPICS

AV Valves Summit 2024 | Opening of Day 2

AV Valves Summit 2024 | Opening of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

AV Valves Summit 2024 | Closing of Day 1

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Case Parade | Tricuspid focus

Case Parade | Tricuspid focus

M. Sitges, R. Estevez, V. Ninios, E. L. Heng, X. Freixa, W. Wojakowski, C. Besler

CONNEXT


TV
RELATED RESOURCES

Case Transmission | Tricuspid focus

Alan's Testimonial

PremiClose 2024: The PDA, when to intervene

LAAO Summit - Imaging debate: Mini TEE

CONNEXT


HUB
RELATED RESOURCES

Amulet IDE Results

The Amulet IDE Trial

Data Summary PFO closure in patients > 60 Years

ESOC 2022 PFO: FAQ

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline